Description: From its introduction, oncological chemotherapy has been encumbered by its poor selectivity because most antiproliferative drugs are toxic not only to tumor cells but also to important populations of the body’s non-neoplastic cells. The resultant problems with unwanted side effects are compounded by difficulties in predicting the desired effectivity of chemotherapy in individual patients. This unsatisfactory situation has driven intensive research and development towards more
View original post here:
Targeted Therapies in Cancer (Deitel; Springer)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.